Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives $23.57 Average PT from Brokerages

Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year […]

Related Keywords

United States , ,Charles Schwab Investment Management Inc ,Stansberry Asset Management ,Caribou Biosciences Inc ,Nasdaq ,Cantor Fitzgerald ,Citigroup ,Fund Management Co ,Caribou Biosciences ,Get Free Report ,Marketbeat Ratings ,Schwab Investment Management ,Fund Management ,Asset Management ,Get Free ,Caribou Biosciences Daily ,Nasdaq Crbu ,Dcrbu ,Medical ,Ratings ,Consensus ,